Top compounds associated with response to PYGL


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC -0.022 0.6
mRNA tivozanib GDSC1000 pan-cancer AAC 0.11 0.003
mRNA tivozanib CTRPv2 pan-cancer AAC 0.043 0.2
mRNA tosedostat CTRPv2 pan-cancer AAC -0.049 0.2
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.041 0.3
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.0073 0.8
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.018 0.6
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.1 0.01
mRNA triptolide CTRPv2 pan-cancer AAC 0.063 0.08
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.09 0.08
Download CSV